Mast Cell And Inflammatory Bowel Disease
Copyright ©The Author(s) 2004.
World J Gastroenterol. Feb 1, 2004; 10(3): 332-336
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.332
Figure 1
Figure 1 Inhibition of anti-IgE (10 µg/mL) induced tryptase release from dispersed colon mast cells by protease inhibitors. The inhibitors and anti-IgE were added to cells at the same time (no preincubation). Data are presented as mean ± SEM for four to six separate experiments performed in duplicate. aP < 0.05 compared with the responses with uninhibited controls. AT = α1-antitrypsin; LF = lactoferrin.
Figure 2
Figure 2 Inhibition of anti-IgE (10 µg/mL) induced tryptase release from dispersed colon mast cells by protease inhibitors. The inhibitors were preincubated with cells for 20 min before anti-IgE was added. Data are presented as mean ± SEM for four to six separate experiments performed in duplicate. aP < 0.05 compared with the responses of uninhibited controls.
Figure 3
Figure 3 Inhibition of calcium ionophore (1 µg/mL) induced tryptase release from dispersed colon mast cells by protease inhibitors. The inhibitors and anti-IgE were added to cells at the same time (no preincubation). Data are presented as mean ± SEM for four to six separate experiments performed in duplicate. aP < 0.05 compared with the responses with uninhibited controls. AT = α1-antitrypsin; LF = lactoferrin.
Figure 4
Figure 4 Inhibition of calcium ionophore (1 µg/mL) induced tryptase release from dispersed colon mast cells by protease inhibitors. The inhibitors were preincubated with cells for 20 min before calcium ionophore was added. Data are pre-sented as mean ± SEM for four to six separate experiments performed in duplicate. aP < 0.05 compared with the responses of uninhibited controls.